Table 3 Pharmacokinetic parameter of major components from C. bergemia using SWISS-ADME tool
From: Potential role of Citrus bergamia flower essential oil against oral pathogens
S.No | Compounds | ||||||
|---|---|---|---|---|---|---|---|
|  | Parameter | limonene | 1–6 octa-diene-3-ol, 3,7-dimethyl (linalool) | p-menth-1-en-8-ol | aromadendrine | β-Myrcine | β-pinene |
1 | GIT Absorbtion | Low | High | High | High | Low | Low |
2 | BBB permeant | Yes | Yes | Yes | No | Yes | Yes |
3 | P-gp substrate | No | No | No | No | No | No |
4 | CYP1A2 inhibitor | No | No | No | No | No | No |
6 | CYP2C19 inhibitor | Yes | No | No | No | No | No |
7 | CYP2C9 inhibitor | No | No | Yes | No | No | Yes |
8 | CYP2D6 inhibitor | No | No | No | No | No | No |
9 | CYP3A4 inhibitor | No | No | No | No | No | No |
10 | Log Kp (skin permeation) | -3.89 cm/s | -5.13 cm/s | -4.59 cm/s | -7.13 cm/s | -4.17 cm/s | -4.18 cm/s |